JANX
Janux Therapeutics (JANX)
$79
About Janux Therapeutics (JANX)
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
Details
Daily high
$14.50
Daily low
$13.76
Price at open
$14.10
52 Week High
$61.59
52 Week Low
$13.76
Market cap
829.4M
Dividend yield
0.00%
Volume
7.6M
Avg. volume
3.4M
P/E ratio
-8.23
Janux Therapeutics News
Details
Daily high
$14.50
Daily low
$13.76
Price at open
$14.10
52 Week High
$61.59
52 Week Low
$13.76
Market cap
829.4M
Dividend yield
0.00%
Volume
7.6M
Avg. volume
3.4M
P/E ratio
-8.23